---
layout: post
title: "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Extension of Comment Period"
date: 2026-02-05 19:08:57 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-05318
original_published: 2020-03-16 00:00:00 +0000
significance: 8.00
---

# Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry; Extension of Comment Period

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 16, 2020 00:00 UTC
**Document Number:** 2020-05318

## Summary

The Food and Drug Administration (FDA or Agency) is extending the comment period for the notice entitled "Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry" that appeared in the Federal Register of October 25, 2019. The Agency is taking this action to allow interested persons additional time to submit comments.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/03/16/2020-05318/drug-products-labeled-as-homeopathic-draft-guidance-for-food-and-drug-administration-staff-and)
- API: https://www.federalregister.gov/api/v1/documents/2020-05318

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
